Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000174314 | SCV000167642 | benign | not specified | 2013-01-16 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genetic Services Laboratory, |
RCV000174314 | SCV000192604 | benign | not specified | 2015-08-10 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000174314 | SCV000225595 | benign | not specified | 2015-02-11 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000463106 | SCV000558807 | benign | Developmental and epileptic encephalopathy, 2; Angelman syndrome-like | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics Inc | RCV000174314 | SCV000612716 | benign | not specified | 2017-03-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000717123 | SCV000847969 | likely benign | History of neurodevelopmental disorder | 2016-09-30 | criteria provided, single submitter | clinical testing | Synonymous alterations with insufficient evidence to classify as benign |
Genome Diagnostics Laboratory, |
RCV001705905 | SCV001930180 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000174314 | SCV001972881 | benign | not specified | no assertion criteria provided | clinical testing |